APO Research
Talk to an analyst

APO RESEARCH · REPORT

Allopurinol Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Allopurinol Tablets Industry Growth and Trends Forecast to 2032

20 December 2025101 pages

Choose your research edition.

Industry ResearchAllopurinol Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Allopurinol Tablets Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Allopurinol Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Allopurinol Tablets Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Allopurinol Tablets Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Allopurinol Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Allopurinol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Allopurinol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Allopurinol Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Allopurinol Tablets include Teva, Sun Pharmaceutical, Mylan, Zydus Pharmaceuticals, NorthStar Healthcare, Ipca Laboratories, Dr. Reddys Laboratories, Casper Pharma and APOTEX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Allopurinol Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Allopurinol Tablets market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Allopurinol Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Allopurinol Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Allopurinol Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Allopurinol Tablets Market by Company

Teva

Sun Pharmaceutical

Mylan

Zydus Pharmaceuticals

NorthStar Healthcare

Ipca Laboratories

Dr. Reddys Laboratories

Casper Pharma

APOTEX

Accord Healthcare

Allopurinol Tablets Segment by Type

100 mg

300 mg

Allopurinol Tablets Segment by Application

Gout

Kidney Stones

Allopurinol Tablets Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allopurinol Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Allopurinol Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allopurinol Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Allopurinol Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Allopurinol Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 100 mg Table 2. Major Company of 300 mg Table 3. Global Allopurinol Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Allopurinol Tablets Sales by Type (2021-2026) & (W Units) Table 5. Global Allopurinol Tablets Sales Market Share in Volume by Type (2021-2026) Table 6. Global Allopurinol Tablets Sales by Type (2021-2026) & (US$ Million) Table 7. Global Allopurinol Tablets Sales Market Share in Value by Type (2021-2026) Table 8. Global Allopurinol Tablets Price by Type (2021-2026) & (US$/Unit) Table 9. Global Allopurinol Tablets Sales by Type (2027-2032) & (W Units) Table 10. Global Allopurinol Tablets Sales Market Share in Volume by Type (2027-2032) Table 11. Global Allopurinol Tablets Sales by Type (2027-2032) & (US$ Million) Table 12. Global Allopurinol Tablets Sales Market Share in Value by Type (2027-2032) Table 13. Global Allopurinol Tablets Price by Type (2027-2032) & (US$/Unit) Table 14. North America Allopurinol Tablets Sales by Type (2021-2026) & (W Units) Table 15. North America Allopurinol Tablets Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Allopurinol Tablets Sales by Type (2021-2026) & (W Units) Table 17. Europe Allopurinol Tablets Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Allopurinol Tablets Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Allopurinol Tablets Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Allopurinol Tablets Sales by Type (2021-2026) & (W Units) Table 21. Latin America Allopurinol Tablets Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Allopurinol Tablets Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Allopurinol Tablets Sales by Type (2021-2026) & (US$ Million) Table 24. Allopurinol Tablets Industry Trends Table 25. Allopurinol Tablets Industry Drivers Table 26. Allopurinol Tablets Industry Opportunities and Challenges Table 27. Allopurinol Tablets Industry Restraints Table 28. Global Allopurinol Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Allopurinol Tablets Revenue Market Share by Company (2021-2026) Table 30. Global Allopurinol Tablets Sales by Company (2021-2026) & (W Units) Table 31. Global Allopurinol Tablets Sales Share by Company (2021-2026) Table 32. Global Allopurinol Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Allopurinol Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Allopurinol Tablets Major Company Production Sites and Headquarters Table 35. Global Allopurinol Tablets Company, Product Type & Application Table 36. Global Allopurinol Tablets Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Allopurinol Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Allopurinol Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Allopurinol Tablets Sales by Region (2021-2026) & (W Units) Table 41. Global Allopurinol Tablets Sales Market Share in Volume by Region (2021-2026) Table 42. Global Allopurinol Tablets Sales by Region (2021-2026) & (US$ Million) Table 43. Global Allopurinol Tablets Sales Market Share in Value by Region (2021-2026) Table 44. Global Allopurinol Tablets Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Allopurinol Tablets Sales by Region (2027-2032) & (W Units) Table 46. Global Allopurinol Tablets Sales Market Share in Volume by Region (2027-2032) Table 47. Global Allopurinol Tablets Sales by Region (2027-2032) & (US$ Million) Table 48. Global Allopurinol Tablets Sales Market Share in Value by Region (2027-2032) Table 49. Global Allopurinol Tablets Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Allopurinol Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Allopurinol Tablets Sales by Application (2021-2026) & (W Units) Table 52. Global Allopurinol Tablets Sales Market Share in Volume by Application (2021-2026) Table 53. Global Allopurinol Tablets Sales by Application (2021-2026) & (US$ Million) Table 54. Global Allopurinol Tablets Sales Market Share in Value by Application (2021-2026) Table 55. Global Allopurinol Tablets Price by Application (2021-2026) & (US$/Unit) Table 56. Global Allopurinol Tablets Sales by Application (2027-2032) & (W Units) Table 57. Global Allopurinol Tablets Sales Market Share in Volume by Application (2027-2032) Table 58. Global Allopurinol Tablets Sales by Application (2027-2032) & (US$ Million) Table 59. Global Allopurinol Tablets Sales Market Share in Value by Application (2027-2032) Table 60. Global Allopurinol Tablets Price by Application (2027-2032) & (US$/Unit) Table 61. North America Allopurinol Tablets Sales by Application (2021-2026) & (W Units) Table 62. North America Allopurinol Tablets Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Allopurinol Tablets Sales by Application (2021-2026) & (W Units) Table 64. Europe Allopurinol Tablets Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Allopurinol Tablets Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Allopurinol Tablets Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Allopurinol Tablets Sales by Application (2021-2026) & (W Units) Table 68. Latin America Allopurinol Tablets Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Allopurinol Tablets Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Allopurinol Tablets Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Allopurinol Tablets Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Allopurinol Tablets Product Portfolio Table 75. Teva Recent Development Table 76. Sun Pharmaceutical Company Information Table 77. Sun Pharmaceutical Business Overview Table 78. Sun Pharmaceutical Allopurinol Tablets Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Sun Pharmaceutical Allopurinol Tablets Product Portfolio Table 80. Sun Pharmaceutical Recent Development Table 81. Mylan Company Information Table 82. Mylan Business Overview Table 83. Mylan Allopurinol Tablets Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Mylan Allopurinol Tablets Product Portfolio Table 85. Mylan Recent Development Table 86. Zydus Pharmaceuticals Company Information Table 87. Zydus Pharmaceuticals Business Overview Table 88. Zydus Pharmaceuticals Allopurinol Tablets Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Zydus Pharmaceuticals Allopurinol Tablets Product Portfolio Table 90. Zydus Pharmaceuticals Recent Development Table 91. NorthStar Healthcare Company Information Table 92. NorthStar Healthcare Business Overview Table 93. NorthStar Healthcare Allopurinol Tablets Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. NorthStar Healthcare Allopurinol Tablets Product Portfolio Table 95. NorthStar Healthcare Recent Development Table 96. Ipca Laboratories Company Information Table 97. Ipca Laboratories Business Overview Table 98. Ipca Laboratories Allopurinol Tablets Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Ipca Laboratories Allopurinol Tablets Product Portfolio Table 100. Ipca Laboratories Recent Development Table 101. Dr. Reddys Laboratories Company Information Table 102. Dr. Reddys Laboratories Business Overview Table 103. Dr. Reddys Laboratories Allopurinol Tablets Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Dr. Reddys Laboratories Allopurinol Tablets Product Portfolio Table 105. Dr. Reddys Laboratories Recent Development Table 106. Casper Pharma Company Information Table 107. Casper Pharma Business Overview Table 108. Casper Pharma Allopurinol Tablets Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Casper Pharma Allopurinol Tablets Product Portfolio Table 110. Casper Pharma Recent Development Table 111. APOTEX Company Information Table 112. APOTEX Business Overview Table 113. APOTEX Allopurinol Tablets Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. APOTEX Allopurinol Tablets Product Portfolio Table 115. APOTEX Recent Development Table 116. Accord Healthcare Company Information Table 117. Accord Healthcare Business Overview Table 118. Accord Healthcare Allopurinol Tablets Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Accord Healthcare Allopurinol Tablets Product Portfolio Table 120. Accord Healthcare Recent Development Table 121. North America Allopurinol Tablets Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 122. North America Allopurinol Tablets Sales by Country (2021-2026) & (W Units) Table 123. North America Allopurinol Tablets Sales Market Share by Country (2021-2026) Table 124. North America Allopurinol Tablets Sales Forecast by Country (2027-2032) & (W Units) Table 125. North America Allopurinol Tablets Sales Market Share Forecast by Country (2027-2032) Table 126. North America Allopurinol Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Allopurinol Tablets Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Allopurinol Tablets Market Share by Country (2021-2026) Table 129. North America Allopurinol Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Allopurinol Tablets Market Share Forecast by Country (2027-2032) Table 131. Europe Allopurinol Tablets Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 132. Europe Allopurinol Tablets Sales by Country (2021-2026) & (W Units) Table 133. Europe Allopurinol Tablets Sales Market Share by Country (2021-2026) Table 134. Europe Allopurinol Tablets Sales Forecast by Country (2027-2032) & (W Units) Table 135. Europe Allopurinol Tablets Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Allopurinol Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Allopurinol Tablets Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Allopurinol Tablets Market Share by Country (2021-2026) Table 139. Europe Allopurinol Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Allopurinol Tablets Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Allopurinol Tablets Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Allopurinol Tablets Sales by Country (2021-2026) & (W Units) Table 143. Asia-Pacific Allopurinol Tablets Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Allopurinol Tablets Sales Forecast by Country (2027-2032) & (W Units) Table 145. Asia-Pacific Allopurinol Tablets Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Allopurinol Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Allopurinol Tablets Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Allopurinol Tablets Market Share by Country (2021-2026) Table 149. Asia-Pacific Allopurinol Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Allopurinol Tablets Market Share Forecast by Country (2027-2032) Table 151. Latin America Allopurinol Tablets Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 152. Latin America Allopurinol Tablets Sales by Country (2021-2026) & (W Units) Table 153. Latin America Allopurinol Tablets Sales Market Share by Country (2021-2026) Table 154. Latin America Allopurinol Tablets Sales Forecast by Country (2027-2032) & (W Units) Table 155. Latin America Allopurinol Tablets Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Allopurinol Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Allopurinol Tablets Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Allopurinol Tablets Market Share by Country (2021-2026) Table 159. Latin America Allopurinol Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Allopurinol Tablets Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Allopurinol Tablets Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Allopurinol Tablets Sales by Country (2021-2026) & (W Units) Table 163. Middle East and Africa Allopurinol Tablets Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Allopurinol Tablets Sales Forecast by Country (2027-2032) & (W Units) Table 165. Middle East and Africa Allopurinol Tablets Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Allopurinol Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Allopurinol Tablets Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Allopurinol Tablets Market Share by Country (2021-2026) Table 169. Middle East and Africa Allopurinol Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Allopurinol Tablets Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Allopurinol Tablets Distributors List Table 174. Allopurinol Tablets Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Allopurinol Tablets Image Figure 2. Global Allopurinol Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Allopurinol Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Allopurinol Tablets Sales (2021-2032) & (W Units) Figure 5. 100 mg Image Figure 6. Global 100 mg Sales YoY Growth (2021-2032) & (W Units) Figure 7. 300 mg Image Figure 8. Global 300 mg Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Allopurinol Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Allopurinol Tablets Market Share by Type 2025 VS 2032 Figure 11. North America Allopurinol Tablets Sales Market Share in Volume by Type in 2025 Figure 12. North America Allopurinol Tablets Sales Market Share in Value by Type in 2025 Figure 13. Europe Allopurinol Tablets Sales Market Share in Volume by Type in 2025 Figure 14. Europe Allopurinol Tablets Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Allopurinol Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Allopurinol Tablets Sales Market Share in Value by Type in 2025 Figure 17. Latin America Allopurinol Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Allopurinol Tablets Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Allopurinol Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Allopurinol Tablets Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Allopurinol Tablets Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Gout Image Figure 24. Global Gout Sales YoY Growth (2021-2032) & (W Units) Figure 25. Kidney Stones Image Figure 26. Global Kidney Stones Sales YoY Growth (2021-2032) & (W Units) Figure 27. Global Allopurinol Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Allopurinol Tablets Market Share by Application 2025 VS 2032 Figure 29. North America Allopurinol Tablets Sales Market Share in Volume by Application in 2025 Figure 30. North America Allopurinol Tablets Sales Market Share in Value by Application in 2025 Figure 31. Europe Allopurinol Tablets Sales Market Share in Volume by Application in 2025 Figure 32. Europe Allopurinol Tablets Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Allopurinol Tablets Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Allopurinol Tablets Sales Market Share in Value by Application in 2025 Figure 35. Latin America Allopurinol Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Allopurinol Tablets Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Allopurinol Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Allopurinol Tablets Sales Market Share in Value by Application in 2025 Figure 39. North America Allopurinol Tablets Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 40. North America Allopurinol Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Allopurinol Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Allopurinol Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Allopurinol Tablets Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. Europe Allopurinol Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Allopurinol Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Allopurinol Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Allopurinol Tablets Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Asia-Pacific Allopurinol Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Allopurinol Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Allopurinol Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Allopurinol Tablets Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Latin America Allopurinol Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Allopurinol Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Allopurinol Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Allopurinol Tablets Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Middle East and Africa Allopurinol Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Allopurinol Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Allopurinol Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Allopurinol Tablets Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Allopurinol Tablets Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 100 mg
  • 300 mg
Applications
  • Gout
  • Kidney Stones
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Mylan
  • Zydus Pharmaceuticals
  • NorthStar Healthcare
  • Ipca Laboratories
  • Dr. Reddys Laboratories
  • Casper Pharma
  • APOTEX
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Allopurinol Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Allopurinol Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Allopurinol Tablets Market by Type
  6. 1.3.1 100 mg
  7. 1.3.2 300 mg
  8. 1.4 Global Allopurinol Tablets Market Size by Type
  9. 1.4.1 Global Allopurinol Tablets Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Allopurinol Tablets Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Allopurinol Tablets Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Allopurinol Tablets Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Allopurinol Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Allopurinol Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Allopurinol Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Allopurinol Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Allopurinol Tablets Industry Trends
  2. 2.2 Allopurinol Tablets Industry Drivers
  3. 2.3 Allopurinol Tablets Industry Opportunities and Challenges
  4. 2.4 Allopurinol Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Allopurinol Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Allopurinol Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Allopurinol Tablets Price (2021-2026)
  4. 3.4 Global Allopurinol Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Allopurinol Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Allopurinol Tablets Company, Product Type & Application
  7. 3.7 Global Allopurinol Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Allopurinol Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Allopurinol Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Allopurinol Tablets Tier 1, Tier 2, and Tier 3
4 Allopurinol Tablets Regional Status and Outlook
  1. 4.1 Global Allopurinol Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Allopurinol Tablets Historic Market Size by Region
  3. 4.2.1 Global Allopurinol Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Allopurinol Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Allopurinol Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Allopurinol Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Allopurinol Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Allopurinol Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Allopurinol Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Allopurinol Tablets by Application
  1. 5.1 Allopurinol Tablets Market by Application
  2. 5.1.1 Gout
  3. 5.1.2 Kidney Stones
  4. 5.2 Global Allopurinol Tablets Market Size by Application
  5. 5.2.1 Global Allopurinol Tablets Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Allopurinol Tablets Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Allopurinol Tablets Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Allopurinol Tablets Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Allopurinol Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Allopurinol Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Allopurinol Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Allopurinol Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Allopurinol Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Allopurinol Tablets Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sun Pharmaceutical
  8. 6.2.1 Sun Pharmaceutical Company Information
  9. 6.2.2 Sun Pharmaceutical Business Overview
  10. 6.2.3 Sun Pharmaceutical Allopurinol Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Allopurinol Tablets Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Allopurinol Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Allopurinol Tablets Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Zydus Pharmaceuticals
  20. 6.4.1 Zydus Pharmaceuticals Company Information
  21. 6.4.2 Zydus Pharmaceuticals Business Overview
  22. 6.4.3 Zydus Pharmaceuticals Allopurinol Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Zydus Pharmaceuticals Allopurinol Tablets Product Portfolio
  24. 6.4.5 Zydus Pharmaceuticals Recent Developments
  25. 6.5 NorthStar Healthcare
  26. 6.5.1 NorthStar Healthcare Company Information
  27. 6.5.2 NorthStar Healthcare Business Overview
  28. 6.5.3 NorthStar Healthcare Allopurinol Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 NorthStar Healthcare Allopurinol Tablets Product Portfolio
  30. 6.5.5 NorthStar Healthcare Recent Developments
  31. 6.6 Ipca Laboratories
  32. 6.6.1 Ipca Laboratories Company Information
  33. 6.6.2 Ipca Laboratories Business Overview
  34. 6.6.3 Ipca Laboratories Allopurinol Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Ipca Laboratories Allopurinol Tablets Product Portfolio
  36. 6.6.5 Ipca Laboratories Recent Developments
  37. 6.7 Dr. Reddys Laboratories
  38. 6.7.1 Dr. Reddys Laboratories Company Information
  39. 6.7.2 Dr. Reddys Laboratories Business Overview
  40. 6.7.3 Dr. Reddys Laboratories Allopurinol Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Dr. Reddys Laboratories Allopurinol Tablets Product Portfolio
  42. 6.7.5 Dr. Reddys Laboratories Recent Developments
  43. 6.8 Casper Pharma
  44. 6.8.1 Casper Pharma Company Information
  45. 6.8.2 Casper Pharma Business Overview
  46. 6.8.3 Casper Pharma Allopurinol Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Casper Pharma Allopurinol Tablets Product Portfolio
  48. 6.8.5 Casper Pharma Recent Developments
  49. 6.9 APOTEX
  50. 6.9.1 APOTEX Company Information
  51. 6.9.2 APOTEX Business Overview
  52. 6.9.3 APOTEX Allopurinol Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 APOTEX Allopurinol Tablets Product Portfolio
  54. 6.9.5 APOTEX Recent Developments
  55. 6.10 Accord Healthcare
  56. 6.10.1 Accord Healthcare Company Information
  57. 6.10.2 Accord Healthcare Business Overview
  58. 6.10.3 Accord Healthcare Allopurinol Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Accord Healthcare Allopurinol Tablets Product Portfolio
  60. 6.10.5 Accord Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Allopurinol Tablets Sales by Country
  2. 7.1.1 North America Allopurinol Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Allopurinol Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Allopurinol Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Allopurinol Tablets Market Size by Country
  6. 7.2.1 North America Allopurinol Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Allopurinol Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Allopurinol Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Allopurinol Tablets Sales by Country
  2. 8.1.1 Europe Allopurinol Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Allopurinol Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Allopurinol Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Allopurinol Tablets Market Size by Country
  6. 8.2.1 Europe Allopurinol Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Allopurinol Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Allopurinol Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Allopurinol Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Allopurinol Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Allopurinol Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Allopurinol Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Allopurinol Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Allopurinol Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Allopurinol Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Allopurinol Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Allopurinol Tablets Sales by Country
  2. 10.1.1 South America Allopurinol Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Allopurinol Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Allopurinol Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Allopurinol Tablets Market Size by Country
  6. 10.2.1 South America Allopurinol Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Allopurinol Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Allopurinol Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Allopurinol Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Allopurinol Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Allopurinol Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Allopurinol Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Allopurinol Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Allopurinol Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Allopurinol Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Allopurinol Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Allopurinol Tablets Value Chain Analysis
  2. 12.1.1 Allopurinol Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Allopurinol Tablets Production Mode & Process
  7. 12.2 Allopurinol Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Allopurinol Tablets Distributors
  10. 12.2.3 Allopurinol Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst